SCHEMBL5513060

SCHEMBL5513060

CCNCC(F)(C(N)=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
KCNN4 O15554 8/20 0.40
HTT P42858 2/20 0.38
ACSS2 Q9NR19 1/20 0.37
CHRM1 P11229 4/20 0.37
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM3 P20309 2/20 0.36
LMNA P02545 2/20 0.36
CHRM2 P08172 1/20 0.36
CYP2D6 P10635 1/20 0.36
KCNH2 Q12809 1/20 0.36
CYP2C19 P33261 2/20 0.36
HIF1A Q16665 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3364484 0.81 MAPT (0.52) MAPTKMT2AKCNN4HTTCHRM1
SCHEMBL4757411 0.78 KMT2A (0.48) MAPTKMT2AKCNN4HTTCHRM1
SCHEMBL23995203 0.73 KCNN4 (0.47) MAPTKMT2AKCNN4LMNACYP2D6
SCHEMBL4063599 0.70 CYP2C19 (0.44) MAPTKMT2AKCNN4CHRM1CHRM4
SCHEMBL27270010 0.69 KCNN4 (0.50) KMT2AKCNN4HTTLMNAL3MBTL1
SCHEMBL2013207 0.68 CYP2C19 (0.53) KMT2AKCNN4HTTLMNACYP2C19
Trifluoromethylbenzene SCHEMBL10587298 0.68 ALDH1A1 (0.56) MAPTKMT2AKCNN4HTTCYP2C19
SCHEMBL2699401 0.68 MAPT (0.48) MAPTKMT2AKCNN4HTTCHRM1
SCHEMBL1822224 0.67 MAPT (0.63) MAPTKMT2AKCNN4HTTCYP2D6
SCHEMBL19413917 0.67 TAAR1 (0.50) KMT2AKCNN4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1797032-A1 POLYMORPHS OF THE CYSTEINE PROTEASE INHIBITOR N-(1-CYANOCYCLOPROPYL)-3-CYCLOPROPYLMETHANESULFONYL-2(R)-[2,2,2-TRIFLUORO-1(S)-(4-FLUOROPHENYL)ETHYLAMINO]PROPIONAMIDE Bayer Schering Pharma Aktiengesellschaft (DE) 2007-06-20 EP disclosed
WO-2006034006-A1 POLYMORPHS OF THE CYSTEINE PROTEASE INHIBITOR N- (1-CYANOCYCLOPROPYL)-3-CYCLOPROPYLMETHANSULFONYL-2 (R) - (2,2,2-TRIFLUORO-1 (S) - (4-FLUOROPHENYL) ETHYLAMINO) PROPIONAMIDE SCHERING AKTIENGESELLSCHAFT (DE) 2006-03-30 WO disclosed